Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma.
about
Structural Insights into High Density Lipoprotein: Old Models and New FactsStructural basis for distinct functions of the naturally occurring Cys mutants of human apolipoprotein A-INew insights into the determination of HDL structure by apolipoproteins: Thematic review series: high density lipoprotein structure, function, and metabolismAtheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P)Nanoparticle Targeting and Cholesterol Flux Through Scavenger Receptor Type B-1 Inhibits Cellular Exosome Uptake.The Structure of Dimeric Apolipoprotein A-IV and Its Mechanism of Self-AssociationAmyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosisA model of lipid-free apolipoprotein A-I revealed by iterative molecular dynamics simulationThe structure of human apolipoprotein A-IV as revealed by stable isotope-assisted cross-linking, molecular dynamics, and small angle x-ray scattering.The crystal structure of the C-terminal truncated apolipoprotein A-I sheds new light on amyloid formation by the N-terminal fragment.MD simulations suggest important surface differences between reconstituted and circulating spherical HDL.The value of Apolipoprotein B/Apolipoprotein A1 ratio for metabolic syndrome diagnosis in a Chinese population: a cross-sectional study.Immunochemical Approach for Monitoring of Structural Transition of ApoA-I upon HDL Formation Using Novel Monoclonal AntibodiesA retained secretory signal peptide mediates high density lipoprotein (HDL) assembly and function of haptoglobin-related protein.Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.Arginine-directed glycation and decreased HDL plasma concentration and functionalityApolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein.Definition of human apolipoprotein A-I epitopes recognized by autoantibodies present in patients with cardiovascular diseases.Skeletal muscle insulin resistance associated with cholesterol-induced activation of macrophages is prevented by high density lipoprotein.Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.Quantification of HDL particle concentration by calibrated ion mobility analysis.Small HDL promotes cholesterol efflux by the ABCA1 pathway in macrophages: implications for therapies targeted to HDL.Conformational transitions in the membrane scaffold protein of phospholipid bilayer nanodiscsCubbing in proapolipoprotein maturation.Role of Conserved Proline Residues in Human Apolipoprotein A-IV Structure and Function.Robust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoproteinSerum paraoxonase-3 concentration in HIV-infected patients. Evidence for a protective role against oxidation.Apolipoprotein A-II-mediated conformational changes of apolipoprotein A-I in discoidal high density lipoproteins.Thermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL.Structural stability and functional remodeling of high-density lipoproteins.Apolipoprotein A-I helical structure and stability in discoidal high-density lipoprotein (HDL) particles by hydrogen exchange and mass spectrometry.Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-I monomersNovel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in HumansCrystal structure of Δ(185-243)ApoA-I suggests a mechanistic framework for the protein adaptation to the changing lipid load in good cholesterol: from flatland to sphereland via double belt, belt buckle, double hairpin and trefoil/tetrafoilStructural and functional analysis of APOA5 mutations identified in patients with severe hypertriglyceridemia.Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone.Comparison of apoA-I helical structure and stability in discoidal and spherical HDL particles by HX and mass spectrometry.A comparison of the theoretical relationship between HDL size and the ratio of HDL cholesterol to apolipoprotein A-I with experimental results from the Women's Health Study.Frail HDLs and stiff arteries in type 2 diabetes in juveniles.Patients With Coronary Endothelial Dysfunction Have Impaired Cholesterol Efflux Capacity and Reduced HDL Particle Concentration.
P2860
Q26770434-54A96E59-C712-4AEC-A2C6-5D4E03EE8965Q26823046-74503E4F-E2A2-49A2-9B15-E5A419108362Q26851804-557328CC-5E3E-4212-9396-DD6505C05D9EQ27000801-9C371CB6-9F83-4676-A071-8DF0361DF4C2Q27308074-2ED97EB2-B964-4A26-87FC-00CE0CF1831BQ27679028-B2F211A9-1052-45C8-8A36-EFB27BD30AD3Q28116206-B8BDD7D7-155F-4AC6-A9CE-F41E6CFDF246Q28544802-0E1259A1-8DB4-4A53-B86B-02202FD8974CQ30357908-A429B4ED-510E-4ADD-96CD-734276D37126Q30411501-04885BFD-A1FD-496F-A837-7516E20B2C9DQ30544585-811C43D2-19DE-422B-B018-8A1BB02FC46EQ33697095-B4ECC751-80A9-466B-848C-0E3ACC663931Q33774419-3BAC943D-1021-40ED-BB70-0303602DC065Q34138923-73B6F21E-C5DF-48F1-9527-C3588A9507E6Q34155049-2205F7D1-B63A-4CDE-9C36-A4B542B705E0Q34284245-923610EA-8571-4857-AECF-D303A3218731Q34314185-A77D31D8-15A5-4822-8BB1-D249966C93DEQ34317326-5EB6042C-91C3-4BC9-9539-7F093B3887C7Q34599077-C48D4191-CBEC-4BBB-B2CB-C7DD5D856D40Q35051225-105CFF9B-D9F2-408C-B461-50EC7893FE00Q35073968-60946F90-0243-4782-8E43-8213C4597B96Q35234656-EA291FA8-9DD5-4C76-805A-D620323D661CQ35264725-FCB7C7A0-748D-4B58-A51E-F38ED2CE35B0Q35380046-6D6FB9D6-AB93-4A2A-813D-BA614528A80AQ35536230-ED03636A-07CB-49E7-85B9-860639CC42CAQ35536400-7841B2D3-A7A8-4C7F-897F-03A49C4241DBQ35625941-E70DD77E-AC30-4D48-A1A4-A20B617EA9CAQ35802050-C2FC0BD2-2E4A-4432-96B2-D2613D35E1C1Q35886290-7E669C07-BE43-490B-8236-57BECE90F8E2Q36031087-D4147742-F43D-4B0F-A031-7BAE8D9CD4DEQ36122958-4CC857F5-8537-4761-B57C-17247EC7BD4CQ36145226-2C94759E-8D1E-410A-B150-C56CF36E0A6BQ36403156-851CB4F1-0D24-49FC-AEC1-0DA0C509CD92Q36501281-27079F36-37B6-439E-82C2-3CFFE885F3B7Q36744086-1986FC84-5541-41EF-8756-960B611C7263Q36745091-98B04AA7-9E0B-43CD-886C-2F0218D0AB2CQ36822563-48599FA1-B420-4A72-BB6E-19BAEE852D2AQ36892261-7F96C46C-3060-4CE2-A99B-F988583F5E59Q37030996-2F033A99-50C6-4F48-A062-5C874F508FDBQ37037342-7913496D-2340-492B-85D8-1F2BB612605E
P2860
Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Apolipoprotein A-I structural ...... ns isolated from human plasma.
@ast
Apolipoprotein A-I structural ...... ns isolated from human plasma.
@en
Apolipoprotein A-I structural ...... ns isolated from human plasma.
@nl
type
label
Apolipoprotein A-I structural ...... ns isolated from human plasma.
@ast
Apolipoprotein A-I structural ...... ns isolated from human plasma.
@en
Apolipoprotein A-I structural ...... ns isolated from human plasma.
@nl
prefLabel
Apolipoprotein A-I structural ...... ns isolated from human plasma.
@ast
Apolipoprotein A-I structural ...... ns isolated from human plasma.
@en
Apolipoprotein A-I structural ...... ns isolated from human plasma.
@nl
P2093
P2860
P356
P1476
Apolipoprotein A-I structural ...... ins isolated from human plasma
@en
P2093
Anatol Kontush
Linda K Curtiss
M John Chapman
R A Gangani D Silva
Rong Huang
Timothy J Hodges
W Gray Jerome
P2860
P2888
P304
P356
10.1038/NSMB.2028
P577
2011-03-13T00:00:00Z